4-PIperidin-1-ylbutanenitrile hydrobromide

Catalog No.: 
ACASOV743
CAS No.: 
87145-92-4
Molecular Formula: 
C9H17BrN2
Molecular Weight: 
233.15
4-PIperidin-1-ylbutanenitrile hydrobromide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$104.00InquiryInquiry
1g95%$324.00InquiryInquiry
5g95%$1588.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-PIperidin-1-ylbutanenitrile hydrobromide
IUPAC Name4-(piperidin-1-yl)butanenitrile hydrobromide
MDL No.MFCD27756564
Molecular FormulaC9H17BrN2
Molecular Weight233.15
SMILESN#CCCCN1CCCCC1.Br
InChI KeySVLKGBJIUNEXRJ-UHFFFAOYSA-N
Synonym4-piperidin-1-ylbutanenitrile hydrobromide
CAS No.87145-92-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACASOV743 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBCRN096 route compound structure diagram
    ACBCRN09622840-91-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACASOV743 route product structure diagram
    ACASOV74387145-92-4
Inquiry

2. ACASOV743 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACASOV743 route product structure diagram
    ACASOV74387145-92-4
Inquiry

3. ACASOV743 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACASOV743 route product structure diagram
    ACASOV74387145-92-4
Inquiry

Comments (0)